Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | intermediate filament protein | 0.0026 | 0.0615 | 0.0882 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0016 | 0.0275 | 0.5 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0011 | 0.0085 | 0.0002 |
Schistosoma mansoni | DNA polymerase eta | 0.0016 | 0.0275 | 0.0194 |
Echinococcus multilocularis | musashi | 0.0026 | 0.0615 | 0.0537 |
Trypanosoma brucei | unspecified product | 0.0011 | 0.0105 | 0.1161 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0599 | 0.0858 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0033 | 0.0861 | 0.0785 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0011 | 0.0083 | 0.0118 |
Loa Loa (eye worm) | hypothetical protein | 0.0013 | 0.0155 | 0.0223 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0033 | 0.0861 | 0.1234 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0016 | 0.0275 | 0.0194 |
Echinococcus multilocularis | dna polymerase eta | 0.0016 | 0.0275 | 0.0194 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0016 | 0.0275 | 0.0394 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0011 | 0.0085 | 0.0002 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0033 | 0.0861 | 0.0785 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0016 | 0.0275 | 0.0394 |
Brugia malayi | MH1 domain containing protein | 0.0015 | 0.0221 | 0.0316 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0015 | 0.0221 | 0.0139 |
Brugia malayi | Cytochrome P450 family protein | 0.0011 | 0.0083 | 0.0118 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0015 | 0.0221 | 0.0139 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0011 | 0.0083 | 0.0118 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0037 | 0.0963 | 0.138 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0015 | 0.0221 | 0.0139 |
Onchocerca volvulus | 0.0065 | 0.1936 | 1 | |
Schistosoma mansoni | voltage-gated potassium channel | 0.0011 | 0.0085 | 0.0002 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0037 | 0.0963 | 0.138 |
Schistosoma mansoni | intermediate filament proteins | 0.0026 | 0.0615 | 0.0537 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0016 | 0.0275 | 1 |
Brugia malayi | Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog | 0.0011 | 0.0085 | 0.0122 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0016 | 0.0275 | 0.0394 |
Brugia malayi | MH1 domain containing protein | 0.0015 | 0.0221 | 0.0316 |
Schistosoma mansoni | voltage-gated potassium channel | 0.004 | 0.1076 | 0.1002 |
Echinococcus granulosus | Smad4 | 0.0015 | 0.0221 | 0.0139 |
Brugia malayi | cytochrome P450 | 0.0011 | 0.0083 | 0.0118 |
Loa Loa (eye worm) | Smad1 | 0.0015 | 0.0221 | 0.0316 |
Echinococcus granulosus | lamin | 0.0026 | 0.0615 | 0.0537 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.2463 | 0.3531 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0037 | 0.0963 | 0.0887 |
Leishmania major | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Schistosoma mansoni | smad | 0.0015 | 0.0221 | 0.0139 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Brugia malayi | bZIP transcription factor family protein | 0.0083 | 0.254 | 0.3641 |
Echinococcus granulosus | intermediate filament protein | 0.0026 | 0.0615 | 0.0537 |
Echinococcus multilocularis | jun protein | 0.0083 | 0.254 | 0.2478 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0011 | 0.0105 | 0.1161 |
Trypanosoma brucei | unspecified product | 0.0011 | 0.0105 | 0.1161 |
Brugia malayi | Cytochrome P450 family protein | 0.0011 | 0.0083 | 0.0118 |
Echinococcus granulosus | jun protein | 0.0083 | 0.254 | 0.2478 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0011 | 0.0083 | 0.0118 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Schistosoma mansoni | smad1 5 8 and | 0.0015 | 0.0221 | 0.0139 |
Echinococcus granulosus | dna polymerase eta | 0.0016 | 0.0275 | 0.0194 |
Echinococcus granulosus | lamin dm0 | 0.0026 | 0.0615 | 0.0537 |
Brugia malayi | MH2 domain containing protein | 0.0015 | 0.0221 | 0.0316 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Echinococcus multilocularis | geminin | 0.0303 | 1 | 1 |
Echinococcus multilocularis | dna polymerase kappa | 0.0016 | 0.0275 | 0.0194 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0015 | 0.0221 | 0.0316 |
Brugia malayi | Smad1 | 0.0015 | 0.0221 | 0.0316 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.2013 | 0.1947 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0033 | 0.0861 | 0.0785 |
Echinococcus granulosus | cytoplasmic intermediate filament protein | 0.0013 | 0.0155 | 0.0074 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.0085 | 0.0122 |
Brugia malayi | MH2 domain containing protein | 0.0015 | 0.0221 | 0.0316 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0037 | 0.0963 | 0.0887 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0016 | 0.0275 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0048 | 0.1361 | 0.1951 |
Mycobacterium leprae | putative cytochrome p450 | 0.0011 | 0.0083 | 0.5 |
Leishmania major | DNA polymerase eta, putative | 0.0016 | 0.0275 | 1 |
Loa Loa (eye worm) | cytochrome P450 | 0.0011 | 0.0083 | 0.0118 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0016 | 0.0275 | 0.0194 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0011 | 0.0085 | 0.0002 |
Schistosoma mansoni | smad1 5 8 and | 0.0015 | 0.0221 | 0.0139 |
Schistosoma mansoni | lamin | 0.0026 | 0.0615 | 0.0537 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0033 | 0.0861 | 0.1234 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0033 | 0.0861 | 0.0785 |
Loa Loa (eye worm) | intermediate filament protein | 0.0026 | 0.0615 | 0.0882 |
Schistosoma mansoni | jun-related protein | 0.0068 | 0.2013 | 0.1947 |
Schistosoma mansoni | smad1 5 8 and | 0.0015 | 0.0221 | 0.0139 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0033 | 0.0861 | 0.0785 |
Echinococcus multilocularis | Smad4 | 0.0015 | 0.0221 | 0.0139 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0026 | 0.0615 | 0.0882 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0214 | 0.6976 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.004 | 0.1076 | 0.1002 |
Toxoplasma gondii | cytochrome p450 superfamily protein | 0.0011 | 0.0083 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Schistosoma mansoni | Smad4 | 0.0015 | 0.0221 | 0.0139 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0275 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0016 | 0.0275 | 1 |
Echinococcus granulosus | smad | 0.0015 | 0.0221 | 0.0139 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0016 | 0.0275 | 1 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0015 | 0.0221 | 0.0316 |
Schistosoma mansoni | hypothetical protein | 0.0303 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0048 | 0.1361 | 0.1951 |
Echinococcus granulosus | voltage gated potassium channel | 0.0011 | 0.0085 | 0.0002 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0139 | 0.02 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0011 | 0.0105 | 0.1161 |
Brugia malayi | Cytochrome P450 family protein | 0.0011 | 0.0083 | 0.0118 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0139 | 0.02 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0015 | 0.0221 | 0.0139 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0033 | 0.0861 | 0.0785 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0014 | 0.0203 | 0.029 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0016 | 0.0275 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0016 | 0.0275 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0033 | 0.0861 | 0.0785 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0015 | 0.0221 | 0.0139 |
Brugia malayi | cytoplasmic intermediate filament protein | 0.0014 | 0.0203 | 0.029 |
Echinococcus multilocularis | lamin | 0.0026 | 0.0615 | 0.0537 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0034 | 0.0881 | 1 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0011 | 0.0083 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0011 | 0.0105 | 0.1161 |
Echinococcus multilocularis | smad | 0.0015 | 0.0221 | 0.0139 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0016 | 0.0275 | 1 |
Brugia malayi | hypothetical protein | 0.0065 | 0.1936 | 0.2775 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0214 | 0.6976 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0615 | 0.0882 |
Giardia lamblia | DINP protein human, muc B family | 0.0016 | 0.0275 | 0.5 |
Echinococcus granulosus | dna polymerase kappa | 0.0016 | 0.0275 | 0.0194 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0016 | 0.0275 | 1 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0016 | 0.0275 | 0.0194 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0083 | 0.254 | 0.2478 |
Echinococcus multilocularis | lamin dm0 | 0.0026 | 0.0615 | 0.0537 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0016 | 0.0275 | 1 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0034 | 0.0881 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0799 | 0.1146 |
Schistosoma mansoni | lamin | 0.0026 | 0.0615 | 0.0537 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0026 | 0.0615 | 0.0882 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0016 | 0.0275 | 0.0194 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0275 | 0.0394 |
Trypanosoma brucei | unspecified product | 0.0016 | 0.0275 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0214 | 0.6976 | 1 |
Schistosoma mansoni | hypothetical protein | 0.005 | 0.143 | 0.1359 |
Schistosoma mansoni | hypothetical protein | 0.0303 | 1 | 1 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0083 | 0.254 | 0.2478 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0016 | 0.0275 | 1 |
Echinococcus multilocularis | voltage gated potassium channel | 0.0011 | 0.0085 | 0.0002 |
Echinococcus multilocularis | cytoplasmic intermediate filament protein | 0.0013 | 0.0155 | 0.0074 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.